Bi-CAT EIA. For the quantitative determination of epinephrine and norepinphrine in plasma and urine.

Transcription

1 Bi-CAT EIA For the quantitative determination of epinephrine and norepinphrine in plasma and urine. For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 17-BCTHU-E02.1 Size: 2 x 96 wells Version: V ALPCO December 8, G Keewaydin Drive, Salem, NH P: (800) F: (603) ts@alpco.com

2 Bi-CAT ELISA Fast Track 1. Introduction 1.1 Intended use and principle of the test Enzyme Immunoassay for the quantitative determination of adrenaline (epinephrine) and noradrenaline (norepinephrine) in plasma and urine. For Research Use Only. Not for use in Diagnostic Procedures. (epinephrine) and noradrenaline (norepinephrine) are extracted by using a cis-diol-specific affinity gel, acylated and then converted enzymatically. The competitive ELISA kit uses the microtiter plate format. The antigen is bound to the solid phase of the microtiter plate. The derivatized standards, controls and samples and the solid phase bound analytes compete for a fixed number of antibody binding sites. After the system is in equilibrium, free antigen and free antigen-antibody complexes are removed by washing. The antibody bound to the solid phase is detected by an anti-rabbit IgG-peroxidase conjugate using TMB as a substrate. The reaction is monitored at 450 nm. Quantification of unknown samples is achieved by comparing their absorbance with a standard curve prepared with known standard concentrations. 1.2 Research Application In humans the catecholamines adrenaline (epinephrine), noradrenaline (norepinephrine) and dopamine are neurotransmitters of the sympathetic nervous system and are involved in many physiological processes. The sympathetic nervous system sets the body to a heightened state of alert, also called as the body s fight-or-flight response. In the human body the catecholamines and their metabolites indicate the adaption of the body to acute and chronic stress. 2. Procedural cautions, guidelines, warnings and limitations 2.1 Procedural cautions, guidelines and warnings (1) This kit is intended for professional use only. Users should have a thorough understanding of this protocol for the successful use of this kit. Only the test instruction provided with the kit is valid and has to be used to run the assay. Reliable performance will only be attained by strict and careful adherence to the instructions provided. (2) This assay was validated for certain types of samples as indicated in Intended Use (please refer to Chapter 1). Any off-label use of this kit is in the responsibility of the user and the manufacturer cannot be held liable. (3) The principles of Good Laboratory Practice (GLP) have to be followed. (4) In order to reduce exposure to potentially harmful substances, wear lab coats, disposable protective gloves and protective glasses where necessary. (5) All kit reagents and specimens should be brought to room temperature and mixed gently but thoroughly before use. Avoid repeated freezing and thawing of reagents and samples. (6) For dilution or reconstitution purposes, use deionized, distilled, or ultra-pure water. (7) The microplate contains snap-off strips. Unused wells must be stored at 2 C to 8 C in the sealed foil pouch with desiccant and used in the frame provided. (8) Duplicate determination of sample is highly recommended to be able to identify potential pipetting errors. (9) Once the test has been started, all steps should be completed without interruption. Make sure that the required reagents, materials and devices are prepared ready at the appropriate time. (10) Incubation times do influence the results. All wells should be handled in the same order and time intervals. (11) To avoid cross-contamination of reagents, use new disposable pipette tips for dispensing each reagent, sample, standard and control. (12) A standard curve must be established for each run. (13) The controls should be included in each run and fall within established confidence limits. The confidence limits are listed in the QC-Report provided with the kit. (14) Do not mix kit components with different lot numbers within a test and do not use reagents beyond expiry date as shown on the kit labels. (15) Avoid contact with Stop Solution containing 0.25 M H 2SO 4. It may cause skin irritation and burns. In case of contact with eyes or skin, rinse off immediately with water. (16) TMB substrate has an irritant effect on skin and mucosa. In case of possible contact, wash eyes with an abundant volume of water and skin with soap and abundant water. Wash contaminated objects before reusing them. (17) For information on hazardous substances included in the kit please refer to Material Safety Data Sheet (MSDS). The Material Safety Data Sheet for this product is made available directly on the website of the manufacturer or upon request. (18) The expected reference values reported in this test instruction are only indicative. It is recommended that each laboratory establishes its own reference intervals. (19) Kit reagents must be regarded as hazardous waste and disposed according to national regulations. Version: /9

3 2.2 Limitations Any inappropriate handling of samples or modification of this test might influence the results Interfering substances Plasma Samples containing precipitates or fibrin strands or which are hemolytic or lipemic might cause inaccurate results. 24-hour urine Please note the sample preparation and storage! If the percentage of the final concentration of acid is too high, the buffer capacity of the Extraction Buffer is insufficient. As a consequence catecholamines will not be extracted adequately Drug interferences There are no known substances (drugs) which ingestion interferes with the measurement of catecholamine level in the sample. 3. Storage and stability Store the unopened reagents at 2-8 C until expiration date. Do not use components beyond the expiry date indicated on the kit labels. Once opened the reagents are stable for 1 month when stored at 2 8 C. Once the resealable pouch has been opened, care should be taken to close it tightly with desiccant again. 4. Materials 4.1 Content of the kit BA D-0090 Adhesive Foil - Ready to use Adhesive Foils in a resealable pouch 2 x 4 foils BA E-0030 BA E-0040 BA E-0055 BA E-0080 BA E-0131 BA E-0231 BA E-6110 BA E-6210 Wash Buffer Concentrate - Concentrated 50x Buffer with a non-ionic detergent and physiological ph 2 x 20 ml/vial, light purple cap Enzyme Conjugate - Ready to use Goat anti-rabbit immunoglobulins, conjugated with peroxidase 2 x 12 ml/vial, red cap Substrate - Ready to use Chromogenic substrate containing tetramethylbenzidine, substrate buffer and hydrogen peroxide 2 x 12 ml/vial, black cap 0.25 M sulfuric acid 2 x 12 ml/vial, light grey cap Stop Solution - Ready to use Microtiter Strips- Ready to use 1 x 96 well (12x8) antigen precoated microwell plate in a resealable blue pouch with desiccant Microtiter Strips- Ready to use 1 x 96 well (12x8) antigen precoated microwell plate in a resealable yellow pouch with desiccant Antiserum - Ready to use Rabbit anti-adrenaline antibody, blue colored 1 x 6 ml/vial, blue cap Antiserum - Ready to use Rabbit anti-noradrenaline antibody, yellow colored 1 x 6 ml/vial, yellow cap Version: /9

4 BA R-0050 TRIS buffer 1 x 4 ml/vial, green cap Adjustment Buffer - Ready to use Standards and Controls - Ready to use Cat. no. Component Color/ Cap Concentration ng/ml Concentration nmol/l Volume/ Vial BA R-6601 white ml BA R-6602 light yellow ml BA R-6603 orange ml BA R-6604 dark blue ml BA R-6605 light grey ml BA R-6606 black ml BA R-6651 light green Refer to QC report for expected value and 4 ml BA R-6652 dark red acceptable range! 4 ml Conversion: (ng/ml) x 5.46 = (nmol/l) (ng/ml) x 5.91 = (nmol/l) Acidic buffer with non-mercury stabilizer, spiked with defined quantity of adrenaline and noradrenaline BA R-6611 BA R-6612 Hazards identification: Acylation Buffer - Ready to use Buffer with light alkaline ph for the acylation 1 x 20 ml/vial, white cap Acylation Reagent - Ready to use Acylation reagent in DMF and DMSO 1 x 3 ml/vial, light red cap H225 Highly flammable liquid and vapour. H360 May damage fertility or the unborn child. H319 Causes serious eye irritation. BA R-6613 BA R-6614 BA R-6615 BA R-6617 BA R-6618 BA R-6619 Assay Buffer - Ready to use 1M hydrochloric acid and a non-mercury preservative 1 x 6 ml/vial, light grey cap Coenzyme - Ready to use S-adenosyl-L-methionine 1 x 4 ml/vial, purple cap Enzyme - Lyophilized Catechol-O-methyltransferase 4 vials, pink cap Extraction Buffer - Ready to use Buffer containing carbonate 1 x 6 ml/vial, brown cap Extraction Plate - Ready to use 2 x 48 well plates coated with boronate affinity gel in a resealable pouch Hydrochloric Acid - Ready to use M Hydrochloric Acid, yellow colored 1 x 20 ml/vial, dark green cap Version: /9

5 4.2 Additional materials and equipment required but not provided in the kit Calibrated precision pipettes to dispense volumes between µl; 1 ml Microtiter plate washing device (manual, semi-automated or automated) ELISA reader capable of reading absorbance at 450 nm and if possible nm Microtiter plate shaker (shaking amplitude 3 mm; approx. 600 rpm) Absorbent material (paper towel) Water (deionized, distilled, or ultra-pure) Vortex mixer Timer 5. Sample collection and storage Plasma Whole blood should be collected into centrifuge tubes containing EDTA as anti-coagulant ( Monovette or Vacuette for plasma) and centrifuged according to manufacturer s instructions immediately after collection. Hemolytic and lipemic samples should not be used for the assay. Storage: up to 6 hours at 2-8 C, for longer period (up to 6 month) at -20 C. Repeated freezing and thawing should be avoided. Urine Spontaneous urine or 24-hour urine, collected in a bottle containing ml of 6 M HCl, can be used. If 24-hour urine is used please record the total volume of the collected urine. Storage: up to 48 hours at 2-8 C, up to 24 hours at room temperature, for longer periods (up to 6 month) at -20 C. Repeated freezing and thawing should be avoided. Avoid exposure to direct sunlight. 6. Test procedure Allow all reagents to reach room temperature and mix thoroughly by gentle inversion before use. Duplicate determinations are recommended. The binding of the antisera and the enzyme conjugates and the activity of the enzyme used are temperature dependent, and the absorbance may vary if a thermostat is not used. The higher the temperature, the higher the absorbance will be. Varying incubation times will have a similar influence on the absorbance. The optimal temperature during the Enzyme Immunoassay is between C. 6.1 Preparation of reagents Wash Buffer Dilute the 20 ml Wash Buffer Concentrate with water (deionized, distilled, or ultra-pure) to a final volume of 1000 ml. Storage: 1 month at 2 8 C Enzyme Solution Reconstitute the content of the vial labelled Enzyme with 1 ml water (deionized, distilled, or ultra-pure) and mix thoroughly. Add 0.3 ml of Coenzyme followed by 0.7 ml of Adjustment Buffer. The total volume of the Enzyme Solution is 2.0 ml. Note: The Enzyme Solution has to be prepared freshly prior to the assay (not longer than minutes in advance). Discard after use! 6.2 Sample preparation, extraction and acylation 1. Pipette 10 µl of standards, controls, urine samples and 300 µl of plasma samples into the respective wells of the Extraction Plate. 2. Add 250 µl of water (deionized, distilled, or ultra-pure) to the wells with standards, controls and urine samples. 3. Pipette 50 µl of Assay Buffer into all wells. 4. Pipette 50 µl of Extraction Buffer into all wells. 5. Cover plate with Adhesive Foil and incubate 30 min at RT (20 25 C) on a shaker (approx. 600 rpm). 6. Remove the foil. Empty plate and blot dry by tapping the inverted plate on absorbent material. 7. Pipette 1 ml of Wash Buffer into all wells. Incubate the plate for 5 min at RT (20 25 C) on a shaker (approx. 600 rpm). Empty plate and blot dry by tapping the inverted plate on absorbent material. Version: /9

6 8. Pipette another 1 ml of Wash Buffer into all wells. Incubate the plate for 5 min at RT (20 25 C) on a shaker (approx. 600 rpm). Empty plate and blot dry by tapping the inverted plate on absorbent material. 9. Pipette 150 µl of Acylation Buffer into all wells. 10. Pipette 25 µl of Acylation Reagent into all wells. 11. Incubate 15 min at RT (20 25 C) on a shaker (approx. 600 rpm). 12. Empty plate and blot dry by tapping the inverted plate on absorbent material. 13. Pipette 1 ml of Wash Buffer into all wells. Incubate the plate for 10 min at RT (20 25 C) on a shaker (approx. 600 rpm). Empty plate and blot dry by tapping the inverted plate on absorbent material. 14. Pipette 150 µl of Hydrochloric Acid into all wells. 15. Cover plate with Adhesive Foil. Incubate 10 min at RT (20 25 C) on a shaker (approx. 600 rpm). Remove the foil and discard. Do not decant the supernatant thereafter! The following volumes of the supernatant are needed for the subsequent ELISA: 100 µl 20 µl 6.3 ELISA 1. Pipette 25 µl of the Enzyme Solution (refer to 6.1) into all wells of the Microtiter Strips. 2. Pipette 100 µl of the extracted standards, controls and samples into the appropriate wells. 3. Incubate for 30 min at RT (20 25 C) on a shaker (approx. 600 rpm). 4. Pipette 50 µl of the respective Antiserum into all wells and cover plate with Adhesive Foil. 5. Incubate for 2 hours at RT (20 25 C) on a shaker (approx. 600 rpm). 6. Remove the foil. Discard or aspirate the content of the wells. Wash the plate 3 times by adding 300 µl of Wash Buffer, discarding the content and blotting dry each time by tapping the inverted plate on absorbent material. 7. Pipette 100 µl of the Enzyme Conjugate into all wells. 8. Incubate for 30 min at RT (20 25 C) on a shaker (approx. 600 rpm). 9. Discard or aspirate the content of the wells. Wash the plate 3 times by adding 300 µl of Wash Buffer, discarding the content and blotting dry each time by tapping the inverted plate on absorbent material. 10. Pipette 100 µl of the Substrate into all wells and incubate for 25 ± 5 min at RT (20 25 C) on a shaker (approx. 600 rpm). Avoid exposure to direct sunlight! 11. Add 100 µl of the Stop Solution to each well and shake the microtiter plate to ensure a homogeneous distribution of the solution. 12. Read the absorbance of the solution in the wells within 10 minutes, using a microplate reader set to 450 nm (if available a reference wavelength between 620 nm and 650 nm is recommended). 6.4 ELISA 1. Pipette 25 µl of the Enzyme Solution (refer to 6.1) into all wells of the Microtiter Strips. 2. Pipette 20 µl of the extracted standards, controls and samples into the appropriate wells. 3. Incubate for 30 min at RT (20 25 C) on a shaker (approx. 600 rpm). 4. Pipette 50 µl of the Antiserum into all wells and cover plate with Adhesive Foil. 5. Incubate for 2 hours at RT (20 25 C) on a shaker (approx. 600 rpm). 6. Remove the foil. Discard or aspirate the content of the wells. Wash the plate 3 times by adding 300 µl of Wash Buffer, discarding the content and blotting dry each time by tapping the inverted plate on absorbent material. 7. Pipette 100 µl of the Enzyme Conjugate into all wells. 8. Incubate for 30 min at RT (20 25 C) on a shaker (approx. 600 rpm). Version: /9

7 9. Discard or aspirate the content of the wells. Wash the plate 3 times by adding 300 µl of Wash Buffer, discarding the content and blotting dry each time by tapping the inverted plate on absorbent material. 10. Pipette 100 µl of the Substrate into all wells and incubate for 25 ± 5 min at RT (20 25 C) on a shaker (approx. 600 rpm). Avoid exposure to direct sunlight! 11. Add 100 µl of the Stop Solution to each well and shake the microtiter plate to ensure a homogeneous distribution of the solution. 12. Read the absorbance of the solution in the wells within 10 minutes, using a microplate reader set to 450 nm (if available a reference wavelength between 620 nm and 650 nm is recommended). 7. Calculation of results Measuring range Urine ng/ml ng/ml Plasma pg/ml pg/ml The standard curves are obtained by plotting the absorbance readings (calculate the mean absorbance) of the standards (linear, y-axis) against the corresponding standard concentrations (logarithmic, x-axis). Use a non-linear regression for curve fitting (e.g. spline, 4- parameter, akima). Note: This assay is a competitive assay. This means: the OD-values are decreasing with increasing concentrations of the analyte. OD-values found below the standard curve correspond to high concentrations of the analyte in the sample and have to be reported as being positive. Urine samples and controls The concentrations of the urine samples and the Controls can be read directly from the standard curve. Calculate the 24 h excretion for each urine sample: µg/24h = µg/l x l/24h Plasma samples The read concentrations of the plasma samples have to be divided by 30. Conversion (ng/ml) x 5.46 = (nmol/l) (ng/ml) x 5.91 = (nmol/l) 7.1 Quality control It is recommended to use control samples according to national regulations. Use controls at both normal and pathological levels. The kit or other commercial controls should fall within established confidence limits. The confidence limits of the kit controls are printed on the QC-Report. 7.2 Typical standard curves Examples, do not use for calculation! OD ng/ml ng/ml Version: /9

8 8. Assay characteristics Analytical Sensitivity LOD LOQ Urine (ng/ml) Plasma (pg/ml) Urine (ng/ml) Plasma (pg/ml) Analytical Specificity (Cross Reactivity) Substance Cross Reactivity (%) Derivatized Derivatized Derivatized Dopamine < Metanephrine 0.18 < 0.01 Normetanephrine < Methoxytyramine < 0.01 < Methoxy-4-hydroxyphenylglycol < 0.01 < 0.01 Tyramine < 0.01 < 0.01 Phenylalanine, Caffeinic acid, L-Dopa, Homovanillic acid, Tyrosine, 3-Methoxy-4-hydroxymandelic acid < 0.01 < 0.01 Precision Intra-Assay Urine (n = 60) Intra-Assay Plasma (n = 60) Sample Range (ng/ml) CV (%) Sample Range (pg/ml) CV (%) ± ± ± ± ± ± ± ± ± ± ± ± Inter-Assay Urine (n = 33) Inter-Assay Plasma (n = 18) Sample Range (ng/ml) CV (%) Sample Range (pg/ml) CV (%) ± ± ± ± ± ± ± ± ± ± ± ± Linearity Serial dilution up to Range (%) Mean (%) Urine 1: Plasma 1: Urine 1: Plasma 1: Recovery Mean (%) Range (%) Range Urine ng/ml Plasma pg/ml Urine ng/ml Plasma pg/ml 9. References/Literature (1) Kim et al. Vitamin C prevents stress-induced damage on the heart caused by the death of cardiomyocytes, through the down-regulation of the excessive production of catecholamine, TNF-α, and Version: /9

9 ROS production in GULO(-I-) Vit C-Insufficient mice. Free Radical Biology and Medicine, 65: (2013) (2) Bada et al. Peripheral vasodilatation determines cardiac output in exercising humans: insight from atrial pacing. The Journal of Physiology, 590(8): (2012) (3) Parks et al. Employment and work schedule are related to telomere length in women. Occupational & Environmental Medicine 68(8): (2011) Symbols: For updated literature or any other information please contact your local supplier. Storage temperature Manufacturer Contains sufficient for <n> tests Expiry date Consult instructions for use Caution Batch code Content Catalogue number For in-vitro diagnostic use only! CE labelled For research use only! Version: /9